Terns Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 11/14/2024 | 7.56 M | $63.08 M | -0.74% | 9.72% |
| VIVO CAPITAL, LLC | 11/13/2024 | 6.90 M | $57.51 M | 11.53% | 8.86% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 6.22 M | $51.90 M | 25.79% | 8.00% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 5.58 M | $46.51 M | -8.58% | 7.17% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.70 M | $39.19 M | 100.00% | 6.04% |
| CITADEL ADVISORS LLC | 11/14/2024 | 3.67 M | $30.63 M | 151.60% | 4.72% |
| VR ADVISER, LLC | 11/14/2024 | 3.41 M | $28.44 M | 0.00% | 4.38% |
| VANGUARD GROUP INC | 11/13/2024 | 3.36 M | $28.00 M | 45.89% | 4.31% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 3.29 M | $27.44 M | 45.03% | 4.23% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 2.71 M | $22.58 M | 0.64% | 3.48% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 2.13 M | $17.80 M | 100.00% | 2.74% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 2.09 M | $17.45 M | 92.99% | 2.69% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 2.02 M | $16.82 M | 169.84% | 2.59% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 1.65 M | $13.75 M | 100.00% | 2.12% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.58 M | $13.16 M | 38.42% | 2.03% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 1.48 M | $12.31 M | 5,430.41% | 1.90% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 11/14/2024 | 1.35 M | $11.25 M | 40.98% | 1.73% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.21 M | $10.07 M | 7.63% | 1.55% |
| FMR LLC | 11/13/2024 | 1.17 M | $9.78 M | -57.63% | 1.51% |
| STATE STREET CORP | 11/14/2024 | 1.12 M | $9.32 M | -5.09% | 1.44% |
| BELLEVUE GROUP AG | 11/14/2024 | 1.04 M | $8.69 M | 100.00% | 1.34% |
| MORGAN STANLEY | 11/14/2024 | 782,932 | $6.53 M | 134.68% | 1.01% |
| BOXER CAPITAL, LLC | 11/14/2024 | 752,000 | $6.27 M | 100.00% | 0.97% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 744,687 | $6.21 M | 14.90% | 0.96% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 629,362 | $5.25 M | 69.23% | 0.81% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 600,000 | $5.00 M | 100.00% | 0.77% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 545,751 | $4.55 M | 39.84% | 0.70% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2024 | 487,000 | $4.06 M | 31.88% | 0.63% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 479,500 | $4.00 M | 448.00% | 0.62% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 456,939 | $3.81 M | 100.00% | 0.59% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 449,321 | $3.75 M | 100.00% | 0.58% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 418,867 | $3.49 M | -40.05% | 0.54% |
| SALEM INVESTMENT COUNSELORS INC | 10/15/2024 | 376,600 | $3.14 M | 1.35% | 0.48% |
| ALTIUM CAPITAL MANAGEMENT LP | 11/14/2024 | 330,000 | $2.75 M | 100.00% | 0.42% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 308,497 | $2.57 M | -32.72% | 0.40% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 303,916 | $2.53 M | 801.21% | 0.39% |
| WOODLINE PARTNERS LP | 11/14/2024 | 301,224 | $2.51 M | -59.57% | 0.39% |
| TELEMARK ASSET MANAGEMENT, LLC | 11/12/2024 | 300,000 | $2.50 M | 100.00% | 0.39% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 300,000 | $2.50 M | 100.00% | 0.39% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 249,100 | $2.08 M | -3.79% | 0.32% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 244,576 | $2.04 M | -17.95% | 0.31% |
| CITADEL ADVISORS LLC | 11/14/2024 | 230,700 | $1.92 M | 808.27% | 0.30% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 222,065 | $1.85 M | -0.94% | 0.29% |
| J. GOLDMAN & CO LP | 11/14/2024 | 203,941 | $1.70 M | 100.00% | 0.26% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2024 | 202,348 | $1.69 M | 0.00% | 0.26% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 186,578 | $1.56 M | 100.00% | 0.24% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 185,795 | $1.55 M | 100.00% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 170,100 | $1.42 M | 110.78% | 0.22% |
| CINCTIVE CAPITAL MANAGEMENT LP | 11/14/2024 | 168,564 | $1.41 M | 100.00% | 0.22% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 161,378 | $1.35 M | -8.66% | 0.21% |
Terns Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 180 institutional investors and hedge funds held shares of Terns Pharmaceuticals, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 7.56 M
Vivo Capital, LLC: 6.9 M
Soleus Capital Management, L.P.: 6.22 M
Deep Track Capital, LP: 5.58 M
BlackRock Funding, Inc. /DE: 4.7 M
CITADEL ADVISORS LLC: 3.67 M
102.15% of Terns Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 82.92 M shares in the last 24 months. This purchase volume represents approximately $378.96 M in transactions.